Houyong Dai

410 total citations
20 papers, 342 citations indexed

About

Houyong Dai is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Houyong Dai has authored 20 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Houyong Dai's work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (5 papers) and Connective Tissue Growth Factor Research (3 papers). Houyong Dai is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (5 papers) and Connective Tissue Growth Factor Research (3 papers). Houyong Dai collaborates with scholars based in China and United Kingdom. Houyong Dai's co-authors include Bi‐Cheng Liu, Kun‐Ling Ma, Ri‐Ning Tang, Lin‐Li Lv, Jie Ni, Yide Zhang, Qing Li, Li Yuan, Min Zheng and Weisheng Peng and has published in prestigious journals such as PLoS ONE, Medicine and Clinica Chimica Acta.

In The Last Decade

Houyong Dai

20 papers receiving 341 citations

Peers

Houyong Dai
Jun Zou China
Birgit Hausknecht Germany
Tracy Clarke United States
Ahmed Elwakiel Germany
Ahmad F. Hedayat United States
Holger Leitolf Germany
Trude Skogstrand Norway
Tatsiana Castor Germany
Mingsheng Zhu China
Joon-Keun Park Germany
Jun Zou China
Houyong Dai
Citations per year, relative to Houyong Dai Houyong Dai (= 1×) peers Jun Zou

Countries citing papers authored by Houyong Dai

Since Specialization
Citations

This map shows the geographic impact of Houyong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houyong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houyong Dai more than expected).

Fields of papers citing papers by Houyong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houyong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houyong Dai. The network helps show where Houyong Dai may publish in the future.

Co-authorship network of co-authors of Houyong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Houyong Dai. A scholar is included among the top collaborators of Houyong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houyong Dai. Houyong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Ying, Yao Wang, Yan Shen, et al.. (2022). A dynamic nomogram for predicting survival among diabetic patients on maintenance hemodialysis. Therapeutic Apheresis and Dialysis. 27(1). 39–49. 2 indexed citations
3.
Chen, Ying, et al.. (2022). A new model to predict acute kidney injury after cardiac surgery in patients with renal insufficiency. Renal Failure. 44(1). 767–776. 4 indexed citations
4.
5.
Ding, Xiaojun, Houyong Dai, Weisheng Peng, et al.. (2018). SB‐216763, a GSK‐3β inhibitor, protects against aldosterone‐induced cardiac, and renal injury by activating autophagy. Journal of Cellular Biochemistry. 119(7). 5934–5943. 21 indexed citations
6.
Dai, Houyong, et al.. (2018). Role of Complement Properdin in Renal Ischemia-Reperfusion Injury. Current Gene Therapy. 17(6). 411–423. 13 indexed citations
7.
Dai, Houyong & Bin Yang. (2018). [Research update of Klotho in kidney injury and repair].. PubMed. 70(6). 639–643. 1 indexed citations
8.
Zhang, Yide, et al.. (2018). Successful pregnancy and delivery in uremic patients with maintenance hemodialysis. Medicine. 97(50). e13614–e13614. 5 indexed citations
9.
Zhang, Yide & Houyong Dai. (2017). The significance of anti-PLA2R antibody for the diagnosis and treatment of idiopathic membranous nephropathy. International Urology and Nephrology. 37(6). 896–899. 1 indexed citations
10.
Dai, Houyong, et al.. (2017). Podocyte Injury in Diabetic Nephropathy. 3(1). 122–129. 2 indexed citations
11.
Dai, Houyong, Yun Cao, Xiaolan Chen, et al.. (2017). Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β‐Catenin Expression and Podocyte Epithelial‐Mesenchymal Transition. Journal of Cellular Biochemistry. 118(11). 3706–3712. 14 indexed citations
12.
Dai, Houyong, et al.. (2016). CTGF mediates high-glucose induced epithelial–mesenchymal transition through activation of β-catenin in podocytes. Renal Failure. 38(10). 1711–1716. 13 indexed citations
13.
Zhang, Yide, Weisheng Peng, Xiang Ao, et al.. (2015). TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury. PLoS ONE. 10(11). e0142456–e0142456. 52 indexed citations
14.
Zhang, Yide, et al.. (2013). The role of renal damage on cardiac remodeling in patients with diabetic nephropathy. Clinical Nephrology. 80(10). 249–255. 7 indexed citations
15.
Dai, Houyong, et al.. (2012). Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats.. PubMed. 125(5). 888–93. 12 indexed citations
16.
Zheng, Min, Lin‐Li Lv, Yuhan Cao, et al.. (2012). A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy. PLoS ONE. 7(5). e34824–e34824. 20 indexed citations
17.
Dai, Houyong, Lin‐Li Lv, Ri‐Ning Tang, et al.. (2011). The roles of connective tissue growth factor and integrin‐linked kinase in high glucose‐induced phenotypic alterations of podocytes. Journal of Cellular Biochemistry. 113(1). 293–301. 31 indexed citations
18.
Tang, Ri‐Ning, Lin‐Li Lv, Jiandong Zhang, et al.. (2011). Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats. International Journal of Cardiology. 162(2). 92–99. 60 indexed citations
19.
Dai, Houyong, Min Zheng, Ri‐Ning Tang, et al.. (2011). Effects of Angiotensin Receptor Blocker on Phenotypic Alterations of Podocytes in Early Diabetic Nephropathy. The American Journal of the Medical Sciences. 341(3). 207–214. 23 indexed citations
20.
Tang, Ri‐Ning, Qing Li, Lin‐Li Lv, et al.. (2010). Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells. Cardiovascular Diabetology. 9(1). 31–31. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Birgit Hausknecht Breakdown of academic impact, for papers by Tracy Clarke Breakdown of academic impact, for papers by Ahmed Elwakiel Breakdown of academic impact, for papers by Ahmad F. Hedayat Breakdown of academic impact, for papers by Holger Leitolf Breakdown of academic impact, for papers by Trude Skogstrand Breakdown of academic impact, for papers by Tatsiana Castor Breakdown of academic impact, for papers by Mingsheng Zhu Breakdown of academic impact, for papers by Joon-Keun Park
Rankless by CCL
2026